OCC 3.23% 45.0¢ orthocell limited

Ann: CelGro Nerve Regeneration Results in Quadriplegic Patients, page-160

  1. 181 Posts.
    lightbulb Created with Sketch. 11
    I hopped in and hopped out at a small profit today. Main reason I thought initially the company has done remarkable things (hello headlines). But it's always the fine print. Not so much fine print ... clearly stated inn the ann!

    Why are the interim nerve regeneration results significant?
    Nerve repair using CelGro® resulted in improvements in muscle power at 12 months that werecomparable to what would normally be expected at 24 months with other methods.

    So what exactly does it do? The claim is stated it works faster than 'other methods'. Do 'other methods' include a person healing naturally with literally no additional surgery? It is not discounted and no direct comparisons are given. So it seems the front page marketing they have used several times of the quadriplegic regaining functions in his arms he would have regained function anyway without using CelGro. Just maybe it happened faster? Who knows.

    Best of luck to your investments.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
45.0¢
Change
-0.015(3.23%)
Mkt cap ! $96.40M
Open High Low Value Volume
47.0¢ 47.0¢ 45.0¢ $81.45K 178.1K

Buyers (Bids)

No. Vol. Price($)
4 17079 45.0¢
 

Sellers (Offers)

Price($) Vol. No.
45.5¢ 32071 2
View Market Depth
Last trade - 15.31pm 13/09/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.